Researchers report that all nine patients who were successfully treated for ADA-SCID in a UCLA clinical trial from 2009 to 2012 are still disease-free.
Research brief: Scientists have identified hundreds of chemical modifications that can alter RNA’s protein-making instructions without affecting the core DNA.
Research brief: A UCLA team has demonstrated that altering a key molecule used in the therapy yields superior and longer-lasting results in mouse models.
Research brief: An approach pioneered at UCLA predicts which methicillin-resistant Staphylococcus aureus infections are likely to be cured with antibiotic therapy.
UCLA astrophysicist Andrea Ghez and UC Berkeley biochemist Jennifer Doudna, both 2020 Nobel laureates, will be joined by climate change expert Emily A. Carter.